A Pharmacokinetic Similarity Study in Healthy Male Subjects to Evaluate Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of LY06006 Versus US-Prolia and EU-Prolia by Single-dose Subcutaneous Injection
Clinical trial NCT06095427 · COMPLETED
Trial details
- NCT number
- NCT06095427
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-09
- Primary completion
- 2023-03-14
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.